Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma

BACKGROUND: Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma. Histone deacetylase inhibitors (HDACis) have been widely applied in multiple tumours, but the expected efficacy was not observed in DLBCL. Therefore, this study is aimed to explore superior HDACis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luqiao, Wu, Zijuan, Xia, Yi, Lu, Xueying, Li, Ji, Fan, Lei, Qiao, Chun, Qiu, Hairong, Gu, Danling, Xu, Wei, Li, Jianyong, Jin, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076017/
https://www.ncbi.nlm.nih.gov/pubmed/35522945
http://dx.doi.org/10.1002/ctm2.798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076017/
https://www.ncbi.nlm.nih.gov/pubmed/35522945
http://dx.doi.org/10.1002/ctm2.798

Ejemplares similares